The relationship between PD-L1 expression and the prognosis of radically resected early-stage NSCLC patients could increase the efficacy of these drugs before or after surgery, and could allow us to better select patients that would benefit from these treatments [37]. Here, CD274 is linked to non-small cell lung carcinoma.